Evidence map›Paper›PMID 37656990›Full record

ArticleBrain : a journal of neurology2024

Inhibiting metabotropic glutamate receptor 5 after stroke restores brain function and connectivity.

Jakob Hakon, Miriana J Quattromani, Carin Sjölund, Daniela Talhada, Byungchan Kim, Slavianka Moyanova, Federica Mastroiacovo, Luisa Di Menna, Roger Olsson, Elisabet Englund and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Channels and Transporters in Ischemic Brain Edema.Journal of inflammation research · 2025
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Jakob HakonDivision of Neurosurgery, Department of Clinical Sciences, Laboratory for Experimental Brain Research, Lund University, Lund 221 84, Sweden.
Miriana J QuattromaniDivision of Neurosurgery, Department of Clinical Sciences, Laboratory for Experimental Brain Research, Lund University, Lund 221 84, Sweden.
Carin SjölundDivision of Neurosurgery, Department of Clinical Sciences, Laboratory for Experimental Brain Research, Lund University, Lund 221 84, Sweden.
Daniela TalhadaDivision of Neurosurgery, Department of Clinical Sciences, Laboratory for Experimental Brain Research, Lund University, Lund 221 84, Sweden.
Byungchan KimDepartment of Radiology, Washington University, Saint Louis, MO 63110, USA.
Slavianka MoyanovaDepartment of Molecular Pathology, IRCCS Neuromed, 86077 Pozzilli, Italy.
Federica MastroiacovoDepartment of Molecular Pathology, IRCCS Neuromed, 86077 Pozzilli, Italy.
Luisa Di MennaDepartment of Molecular Pathology, IRCCS Neuromed, 86077 Pozzilli, Italy.
Roger OlssonDepartment of Experimental Medical Sciences, Chemical Biology & Therapeutics, Lund University, Lund 221 84, Sweden.
Elisabet EnglundDivision of Pathology, Department of Clinical Sciences, Lund University, Lund 221 84, Sweden.
Ferdinando NicolettiDepartment of Molecular Pathology, IRCCS Neuromed, 86077 Pozzilli, Italy.
Karsten RuscherDivision of Neurosurgery, Department of Clinical Sciences, Laboratory for Experimental Brain Research, Lund University, Lund 221 84, Sweden.
Adam Q BauerDepartment of Radiology, Washington University, Saint Louis, MO 63110, USA.
Tadeusz WielochDivision of Neurosurgery, Department of Clinical Sciences, Laboratory for Experimental Brain Research, Lund University, Lund 221 84, Sweden.ORCID 0000-0002-7669-2520
Lund University · SEIstituto Neurologico Mediterraneo · ITWashington University in St. Louis · US

Funding

Imaging and Reversibility of Cellular and Network Metabolic Dysfunction in Alzheimer's DiseaseRF1AG079503 · NIA · WASHINGTON UNIVERSITY · PI BAUER, ADAM Q, GOYAL, MANU S · 2022 to 2022
$2.2M
OPTOGENETIC MAPPING OF CELL SPECIFIC CONNECTIONS IN THE MOUSE BRAIN AFTER STROKER01NS102870 · NINDS · WASHINGTON UNIVERSITY · PI BAUER, ADAM Q · 2018 to 2022
$2.1M
Determining the efficacy of therapeutic interventions after stroke from cell specific functional connectomesR01NS126326 · NINDS · WASHINGTON UNIVERSITY · PI ADAM Q BAUER · 2023 to 2026
$1.8M
NIA NIH HHS RF1 AG079503NINDS NIH HHS R01 NS102870NINDS NIH HHS R01 NS126326
6 · The paper itself

Abstract

Stroke results in local neural disconnection and brain-wide neuronal network dysfunction leading to neurological deficits. Beyond the hyper-acute phase of ischaemic stroke, there is no clinically-approved pharmacological treatment that alleviates sensorimotor impairments. Functional recovery after stroke involves the formation of new or alternative neuronal circuits including existing neural connections. The type-5 metabotropic glutamate receptor (mGluR5) has been shown to modulate brain plasticity and function and is a therapeutic target in neurological diseases outside of stroke. We investigated whether mGluR5 influences functional recovery and network reorganization rodent models of focal ischaemia. Using multiple behavioural tests, we observed that treatment with negative allosteric modulators (NAMs) of mGluR5 (MTEP, fenobam and AFQ056) for 12 days, starting 2 or 10 days after stroke, restored lost sensorimotor functions, without diminishing infarct size. Recovery was evident within hours after initiation of treatment and progressed over the subsequent 12 days. Recovery was prevented by activation of mGluR5 with the positive allosteric modulator VU0360172 and accelerated in mGluR5 knock-out mice compared with wild-type mice. After stroke, multisensory stimulation by enriched environments enhanced recovery, a result prevented by VU0360172, implying a role of mGluR5 in enriched environment-mediated recovery. Additionally, MTEP treatment in conjunction with enriched environment housing provided an additive recovery enhancement compared to either MTEP or enriched environment alone. Using optical intrinsic signal imaging, we observed brain-wide disruptions in resting-state functional connectivity after stroke that were prevented by mGluR5 inhibition in distinct areas of contralesional sensorimotor and bilateral visual cortices. The levels of mGluR5 protein in mice and in tissue samples of stroke patients were unchanged after stroke. We conclude that neuronal circuitry subserving sensorimotor function after stroke is depressed by a mGluR5-dependent maladaptive plasticity mechanism that can be restored by mGluR5 inhibition. Post-acute stroke treatment with mGluR5 NAMs combined with rehabilitative training may represent a novel post-acute stroke therapy.

Indexed as

Brain IschemiaNervous System DiseasesStrokeAnimalsBrainHumansMiceMice, KnockoutReceptor, Metabotropic Glutamate 5Grm5 protein, mouseReceptor, Metabotropic Glutamate 5long term depressionpharmacological therapyplasticityresting-state functional connectivitystroke recovery

Identifiers

PMID37656990
PMCPMC10766240
OpenAlexW4386383964

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.